Amgen Inc (AMGN)
316.98
-2.24
(-0.70%)
USD |
NASDAQ |
Nov 04, 16:00
317.99
+1.01
(+0.32%)
Pre-Market: 08:38
Amgen Free Cash Flow: 6.283B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.283B |
| June 30, 2024 | 5.481B |
| March 31, 2024 | 7.098B |
| December 31, 2023 | 7.359B |
| September 30, 2023 | 9.379B |
| June 30, 2023 | 9.685B |
| March 31, 2023 | 7.531B |
| December 31, 2022 | 8.785B |
| September 30, 2022 | 8.997B |
| June 30, 2022 | 8.355B |
| March 31, 2022 | 8.417B |
| December 31, 2021 | 8.381B |
| September 30, 2021 | 7.84B |
| June 30, 2021 | 8.897B |
| March 31, 2021 | 9.835B |
| December 31, 2020 | 9.889B |
| September 30, 2020 | 10.24B |
| June 30, 2020 | 10.21B |
| March 31, 2020 | 8.795B |
| December 31, 2019 | 8.532B |
| September 30, 2019 | 9.175B |
| June 30, 2019 | 9.07B |
| March 31, 2019 | 9.715B |
| December 31, 2018 | 10.56B |
| September 30, 2018 | 10.45B |
| Date | Value |
|---|---|
| June 30, 2018 | 10.64B |
| March 31, 2018 | 10.87B |
| December 31, 2017 | 10.51B |
| September 30, 2017 | 10.53B |
| June 30, 2017 | 9.825B |
| March 31, 2017 | 10.07B |
| December 31, 2016 | 9.616B |
| September 30, 2016 | 8.611B |
| June 30, 2016 | 8.821B |
| March 31, 2016 | 9.532B |
| December 31, 2015 | 9.137B |
| September 30, 2015 | 9.773B |
| June 30, 2015 | 9.39B |
| March 31, 2015 | 8.343B |
| December 31, 2014 | 7.949B |
| September 30, 2014 | 7.079B |
| June 30, 2014 | 6.29B |
| March 31, 2014 | 5.677B |
| December 31, 2013 | 5.598B |
| September 30, 2013 | 4.551B |
| June 30, 2013 | 4.469B |
| March 31, 2013 | 5.231B |
| December 31, 2012 | 5.168B |
| September 30, 2012 | 5.941B |
| June 30, 2012 | 5.24B |
Free Cash Flow Range, Past 5 Years
5.481B
Minimum
Jun 2024
10.24B
Maximum
Sep 2020
8.499B
Average
8.658B
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 13.15B |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Viking Therapeutics Inc | -74.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.571B |
| Cash from Investing (Quarterly) | -210.00M |
| Cash from Financing (Quarterly) | -3.651B |
| Free Cash Flow Per Share (Quarterly) | 6.114 |
| Free Cash Flow to Equity (Quarterly) | 5.561B |
| Free Cash Flow to Firm (Quarterly) | 4.022B |
| Free Cash Flow Yield | 3.68% |